Colchester Hospital University NHS Foundation Trust
| Type of Trust | |
|---|---|
| NHS hospital trust | |
| Trust Details | |
| Last annual budget | £257 million |
| Employees | |
| Chair | Dr Sally Irvine |
| Chief Executive | |
| Links | |
| Website | Colchester Hospital |
| Care Quality Commission reports | CQC |
| Monitor | Monitor |
Colchester Hospital University NHS Foundation Trust provides healthcare services to around 370,000 people from Colchester and the surrounding area of north east Essex, England. In addition it provides radiotherapy and oncology services to a wider population of about 670,000 across north and mid-Essex. Monitor, the independent regulator of NHS foundation trusts, authorised Essex Rivers Healthcare NHS Trust to become an NHS foundation trust from 1 May 2008.
In 2016 it was announced that was to have a “long term partnership” with Ipswich Hospital NHS Trust and Nick Hulme, the Chief Executive of Ipswich, took charge of it. A future merger is contemplated.
In 2007/08 the Trust employed 3,383 people, 86% of them directly involved in patient care.
The Trust's main acute hospital site, which was opened in 1984, is Colchester General Hospital. The Trust also owns Essex County Hospital in Colchester, which was opened in 1820 and has two wards used for oncology (cancer) patients. The Trust also provides services at Halstead Hospital. At Harwich and Clacton community hospitals, both managed by NHS North East Essex (the PCT), the Trust provides maternity, minor injury and outpatient services.
In 2009 the Chair of the Trust, Richard W. Bourne, was removed by Monitor because it was failing to meet clinical targets.
In November 2013 the Care Quality Commission reported that it had found discrepancies between the hospital's cancer waiting time records and the information contained in patients' individual medical records. 22 out of 61 records showed people had been put "at risk of receiving care that was unsafe or not effective, due to delays in receiving appointments or treatment". In November 2013 the Trust was placed in special measures by Monitor. Gordon Coutts, the chief executive, who had been on sick leave announced on 18 December 2013 that he would not be returning to the post. After an investigation it was concluded that the inaccuracies the hospital's cancer waiting times figures were caused by managerial incompetence rather than bullying of staff.
...
Wikipedia